Sec Form 13G Filing - North Peak Capital Management, LLC filing for - 2025-08-29

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The figures in Items 6, 8, and 9 include (1) 1,247,465 shares of Common stock, par value $0.01 ("Common Stock") of aglion health, inc (the "Issuer") held directly by North Peak Capital Partners, LP, (2) 10,585,833 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 5,564,235 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 878,841 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,423,149 Common Stock outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025 filed with the U.S. Securities and Exchange Commission (the "Commission") on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figures in Items 6, 8, and 9 include (1) 1,247,465 shares of Common Stock held directly by North Peak Capital Partners, LP, (2) 10,585,833 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 5,564,235 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 878,841 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figures in Items 6, 8, and 9 include (1) 1,247,465 shares of Common Stock held directly by North Peak Capital Partners, LP, (2) 10,585,833 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 5,564,235 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 878,841 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The figures in Items 6, 8, and 9 include (1) 1,247,465 shares of Common Stock held directly by North Peak Capital Partners, LP, (2) 10,585,833 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 5,564,235 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 878,841 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,423,149 Common Stock of the Issuer outstanding as of July 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 4, 2025.


SCHEDULE 13G


 
North Peak Capital Management, LLC
 
Signature:/s/ Jeremy Kahan
Name/Title:Jeremy Kahan/Managing Member
Date:08/29/2025
 
North Peak Capital GP, LLC
 
Signature:/s/ Jeremy Kahan
Name/Title:Jeremy Kahan/Manager
Date:08/29/2025
 
North Peak Capital Partners, LP
 
Signature:/s/ Jeremy Kahan
Name/Title:Jeremy Kahan/Manager
Date:08/29/2025
 
North Peak Capital Partners II, LP
 
Signature:/s/ Jeremy Kahan
Name/Title:Jeremy Kahan/Manager
Date:08/29/2025
 
North Peak Capital Alpha Fund, LP
 
Signature:/s/ Jeremy Kahan
Name/Title:Jeremy Kahan/Manager
Date:08/29/2025
 
North Peak Capital Ultra Fund, LP
 
Signature:/s/ Jeremy Kahan
Name/Title:Jeremy Kahan/Manager
Date:08/29/2025
 
Michael Kevin Kahan
 
Signature:/s/ Michael Kahan
Name/Title:MICHAEL KAHAN
Date:08/29/2025
 
Jeremy Steven Kahan
 
Signature:/s/ Jeremy Kahan
Name/Title:JEREMY KAHAN
Date:08/29/2025
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (filed herewith)

primary_doc.xml